Literature DB >> 7853169

Marijuana smoking: effects of varying puff volume and breathhold duration.

J L Azorlosa1, M K Greenwald, M L Stitzer.   

Abstract

Two studies were conducted to quantify biological and behavioral effects resulting from exposure to controlled doses of marijuana smoke. In one study, puff volume (30, 60 and 90 ml) and in a second study, breathhold duration (0, 10 and 20 sec) were systematically varied while holding constant other smoking topography parameters (number of puffs = 10, interpuff interval = 60 sec and inhalation volume = 25% of vital capacity). Each study also varied levels of delta 9-tetrahydro-cannabinol marijuana cigarette content (1.75% and 3.55%). Regular marijuana users served as subjects (n = 7 in each experiment). Subjects smoked 10 puffs in each of six sessions; a seventh, nonsmoking session (all measures recorded at the same times as in active smoking sessions) served as a control. Variations in puff volume produced significant dose-related changes in postsmoking plasma delta 9-tetrahydro-cannabinol levels, carbon monoxide boost and subjective effects (e.g., "high"). In contrast, breathholding for 10 or 20 sec versus 0 sec increased plasma delta 9-tetrahydro-cannabinol levels but not CO boost or subjective effects. Task performance measures were not reliably influenced by marijuana smoke exposure within the dosing ranges examined. These findings confirm the utility of the controlled smoking technology, support the notion that cumulative puff volume systematically influences biological exposure and subjective effects, but cast doubt on the common belief that prolonged breathholding of marijuana smoke enhances classical subjective effects associated with its reinforcing value in humans.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7853169

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  17 in total

1.  An exploratory prospective study of marijuana use and mortality following acute myocardial infarction.

Authors:  Kenneth J Mukamal; Malcolm Maclure; James E Muller; Murray A Mittleman
Journal:  Am Heart J       Date:  2008-03       Impact factor: 4.749

2.  Reply to: Managing the high: developing legislation and detection methods for cannabis impairment.

Authors:  Johannes G Ramaekers; Natasha L Mason; Lilian Kloft; Eef L Theunissen
Journal:  Nat Rev Neurosci       Date:  2021-07-20       Impact factor: 34.870

3.  Neurocognition and subjective experience following acute doses of the synthetic cannabinoid JWH-018: a phase 1, placebo-controlled, pilot study.

Authors:  Eef L Theunissen; Nadia R P W Hutten; Natasha L Mason; Stefan W Toennes; Kim P C Kuypers; Eliza B de Sousa Fernandes Perna; Johannes G Ramaekers
Journal:  Br J Pharmacol       Date:  2017-11-29       Impact factor: 8.739

4.  Cannabis effects on driving lateral control with and without alcohol.

Authors:  Rebecca L Hartman; Timothy L Brown; Gary Milavetz; Andrew Spurgin; Russell S Pierce; David A Gorelick; Gary Gaffney; Marilyn A Huestis
Journal:  Drug Alcohol Depend       Date:  2015-06-23       Impact factor: 4.492

5.  Characterizing smoking topography of cannabis in heavy users.

Authors:  Erin A McClure; Maxine L Stitzer; Ryan Vandrey
Journal:  Psychopharmacology (Berl)       Date:  2011-09-16       Impact factor: 4.530

6.  Marijuana effects on human forgetting functions.

Authors:  Scott D Lane; Don R Cherek; Lori M Lieving; Oleg V Tcheremissine
Journal:  J Exp Anal Behav       Date:  2005-01       Impact factor: 2.468

7.  Oral fluid cannabinoid concentrations following controlled smoked cannabis in chronic frequent and occasional smokers.

Authors:  Sebastien Anizan; Garry Milman; Nathalie Desrosiers; Allan J Barnes; David A Gorelick; Marilyn A Huestis
Journal:  Anal Bioanal Chem       Date:  2013-08-17       Impact factor: 4.142

8.  Challenges in quantifying marijuana use.

Authors:  Kevin M Gray; Noreen L Watson; Douglas K Christie
Journal:  Am J Addict       Date:  2009 Mar-Apr

9.  Acute effects of cannabis on breath-holding duration.

Authors:  Samantha G Farris; Jane Metrik
Journal:  Exp Clin Psychopharmacol       Date:  2016-08       Impact factor: 3.157

10.  Δ(9)Tetrahydrocannabinol impairs reversal learning but not extra-dimensional shifts in rhesus macaques.

Authors:  M J Wright; S A Vandewater; L H Parsons; M A Taffe
Journal:  Neuroscience       Date:  2013-01-16       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.